{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:43:04Z","timestamp":1769553784417,"version":"3.49.0"},"reference-count":55,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Clinical management of cancer-associated cachexia, a multi-organ wasting syndrome, has been challenging without effective treatment strategies. An effective treatment that directly targets cancer-induced wasting is desperately needed to improve the quality of life and the survival of cancer patients. Recently, an antibiotic SFX was shown to have anti-tumour and anti-metastatic effects in mouse models of breast cancer. Hence, in this study, we examined the efficacy of SFX in the treatment of cancer-induced cachexia. C26 cachexic mice models were administered with SFX, and the tumour volume and body weight were regularly measured. Blood glucose, skeletal muscles, and adipose tissue were examined at the endpoint. Contrary to a previous study, SFX did not reduce the tumour volume in mice bearing C26 cells. Administration of SFX neither revealed any survival benefit nor rescued C26 cachectic mice from muscle wasting. Interestingly, SFX administration partially rescued (~10%) tumour-induced weight loss by preserving both the subcutaneous and intestinal fat mass. Together, these results suggest that the administration of SFX could partially rescue cancer-induced weight loss by inhibiting lipolysis. As anti-cachexia therapies are scarce, the results could facilitate the design of combinatorial therapies involving SFX, standard-of-care chemotherapeutics, and drugs that inhibit muscle atrophy for the treatment of cancer cachexia.<\/jats:p>","DOI":"10.3390\/biology10080700","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T22:35:31Z","timestamp":1626993331000},"page":"700","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Repurposing of Antibiotic Sulfisoxazole Inhibits Lipolysis in Pre-Clinical Model of Cancer-Associated Cachexia"],"prefix":"10.3390","volume":"10","author":[{"given":"Sai V.","family":"Chitti","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akbar L.","family":"Marzan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5240-1584","authenticated-orcid":false,"given":"Sanjay","family":"Shahi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8790-8705","authenticated-orcid":false,"given":"Taeyoung","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamali","family":"Fonseka","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7290-5795","authenticated-orcid":false,"given":"Suresh","family":"Mathivanan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.qai.0000159627.54149.2e","article-title":"Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003","volume":"40","author":"Tang","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000500760","article-title":"Myostatin Upregulation in Patients in the Chronic Phase of Severe Burn Injury Leads to Muscle Cell Catabolism","volume":"60","author":"Wallner","year":"2019","journal-title":"Eur. Surg. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000227126","article-title":"Clinical management of anorexia and cachexia in patients with advanced cancer","volume":"49","author":"Bruera","year":"1992","journal-title":"Oncology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00109-009-0547-z","article-title":"Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia","volume":"88","author":"Mantovani","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_6","first-page":"389","article-title":"Effect of Megestrol Acetate and Testosterone on Body Composition and Hormonal Responses in COPD Cachexia","volume":"3","author":"Casaburi","year":"2015","journal-title":"Chronic Obstr. Pulm. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.numecd.2013.04.015","article-title":"Plasma adiponectin in heart failure with and without cachexia: Catabolic signal linking catabolism, symptomatic status, and prognosis","volume":"24","author":"Szabo","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cmet.2015.11.003","article-title":"PTH\/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer","volume":"23","author":"Kir","year":"2016","journal-title":"Cell Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/jnnp.46.6.491","article-title":"The natural history of acute painful neuropathy in diabetes mellitus","volume":"46","author":"Archer","year":"1983","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/CS20060265","article-title":"Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis","volume":"112","author":"Klaude","year":"2007","journal-title":"Clin. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-med-061509-131248","article-title":"Muscle wasting in cancer cachexia: Clinical implications, diagnosis, and emerging treatment strategies","volume":"62","author":"Dodson","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MCO.0b013e328300ecc1","article-title":"Cachexia: Prevalence and impact in medicine","volume":"11","author":"Tan","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physiolgenomics.00006.2017","article-title":"Cancer cachexia-induced muscle atrophy: Evidence for alterations in microRNAs important for muscle size","volume":"49","author":"Lee","year":"2017","journal-title":"Physiol. Genom."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3945\/ajcn.113.060228","article-title":"Central tenet of cancer cachexia therapy: Do patients with advanced cancer have exploitable anabolic potential?","volume":"98","author":"Prado","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41568-020-0251-4","article-title":"Understanding cachexia in the context of metastatic progression","volume":"20","author":"Biswas","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.clnu.2016.05.010","article-title":"The 2015 ESPEN Sir David Cuthbertson lecture: Inflammation as the driving force of muscle wasting in cancer","volume":"36","author":"Argiles","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1042\/BST20180213","article-title":"Emerging role of extracellular vesicles in mediating cancer cachexia","volume":"46","author":"Chitti","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1200\/JCO.2012.43.6766","article-title":"Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: A double-blind placebo-controlled trial","volume":"31","author":"Dev","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/cncr.22944","article-title":"A placebo-controlled double blind trial of etanercept for the cancer anorexia\/weight loss syndrome: Results from N00C1 from the North Central Cancer Treatment Group","volume":"110","author":"Jatoi","year":"2007","journal-title":"Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/2277-9175.179182","article-title":"Pentoxifylline treatment in patients with cancer cachexia: A double-blind, randomized, placebo-controlled clinical trial","volume":"5","author":"Mehrzad","year":"2016","journal-title":"Adv. Biomed. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<553::AID-CNCR18>3.0.CO;2-0","article-title":"Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: A randomized, placebo-controlled trial","volume":"82","author":"Simons","year":"1998","journal-title":"Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.1332","article-title":"Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients","volume":"93","author":"Bosaeus","year":"2001","journal-title":"Int. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.cco.0000228738.85626.ac","article-title":"On our way to targeted therapy for cachexia in cancer?","volume":"18","author":"Boddaert","year":"2006","journal-title":"Curr. Opin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/apm.2018.12.08","article-title":"What are the criteria for response to cachexia treatment?","volume":"8","author":"Crawford","year":"2019","journal-title":"Ann. Palliat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s41467-019-09387-4","article-title":"Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A","volume":"10","author":"Im","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1038\/s41467-021-24273-8","article-title":"Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis","volume":"12","author":"Samuel","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Fonseka, P., Kang, T., Chee, S., Chitti, S.V., Sanwlani, R., Ang, C.S., and Mathivanan, S. (2021). Temporal Quantitative Proteomics Analysis of Neuroblastoma Cells Treated with Bovine Milk-Derived Extracellular Vesicles Highlights the Anti-Proliferative Properties of Milk-Derived Extracellular Vesicles. Cells, 10.","DOI":"10.3390\/cells10040750"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/s41467-021-21074-x","article-title":"Sulfisoxazole does not inhibit the secretion of small extracellular vesicles","volume":"12","author":"Fonseka","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1079\/PNS19920036","article-title":"The Sir David Cuthbertson Medal Lecture 1991. The mechanisms and treatment of weight loss in cancer","volume":"51","author":"Fearon","year":"1992","journal-title":"Proc. Nutr Soc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/cncr.21013","article-title":"Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care\u2014correlations with food intake, metabolism, exercise capacity, and hormones","volume":"103","author":"Fouladiun","year":"2005","journal-title":"Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0148607187011003219","article-title":"Body cell mass in cancer-bearing and anorexic patients","volume":"11","author":"Moley","year":"1987","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/jnci\/89.23.1763","article-title":"Biology of Cachexia","volume":"89","author":"Tisdale","year":"1997","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients","volume":"69","author":"Dewys","year":"1980","journal-title":"Am. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/bjc.2011.391","article-title":"Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia","volume":"105","author":"Murphy","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-011-0028-4","article-title":"Combined approach to counteract experimental cancer cachexia: Eicosapentaenoic acid and training exercise","volume":"2","author":"Penna","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/sj.bjc.6602165","article-title":"Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation","volume":"91","author":"Wyke","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/01635581.2011.563032","article-title":"Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo","volume":"63","author":"Shadfar","year":"2011","journal-title":"Nutr. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2014.09.025","article-title":"Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice","volume":"743","author":"Tsubouchi","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1124\/jpet.103.063099","article-title":"Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting","volume":"308","author":"Davis","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_46","first-page":"223","article-title":"Molecular analysis of xenograft models of human cancer cachexia--possibilities for therapeutic intervention","volume":"4","author":"Baumgarten","year":"2007","journal-title":"Cancer Genom. Proteom."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/1097-0215(20000701)87:1<95::AID-IJC14>3.0.CO;2-D","article-title":"Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model","volume":"87","author":"Hussey","year":"2000","journal-title":"Int. J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1006955832323","article-title":"Manipulation of the ubiquitin-proteasome pathway in cachexia: Pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats","volume":"26","author":"Combaret","year":"1999","journal-title":"Mol. Biol. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1042\/bj3610185","article-title":"Torbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic rats","volume":"361","author":"Combaret","year":"2002","journal-title":"Biochem. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s13539-014-0153-y","article-title":"Formoterol in the treatment of experimental cancer cachexia: Effects on heart function","volume":"5","author":"Toledo","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.biocel.2013.07.019","article-title":"Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle","volume":"45","author":"Joassard","year":"2013","journal-title":"Int J. Biochem. Cell Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1152\/japplphysiol.90884.2008","article-title":"Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia","volume":"105","author":"Steffen","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gut.2004.047563","article-title":"Thalidomide in the treatment of cancer cachexia: A randomised placebo controlled trial","volume":"54","author":"Gordon","year":"2005","journal-title":"Gut"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ijc.20089","article-title":"Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy","volume":"110","author":"Kedar","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.physbeh.2007.03.026","article-title":"Forty mouse strain survey of body composition","volume":"91","author":"Reed","year":"2007","journal-title":"Physiol. Behav."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/10\/8\/700\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:33:32Z","timestamp":1760164412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/10\/8\/700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["biology10080700"],"URL":"https:\/\/doi.org\/10.3390\/biology10080700","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}